The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA's Formal Position on Enforcement Discretion Revealed Vapor Technology Association FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures FTC and U.S. FDA Warning Letter re: Products Containing CBD October 22, 2019 Is BPC 157 Banned? Oral vs. Injectable Forms Explained